|
2024 Conference Publication Development of venom peptide inhibitors of acid-sensing ion channel 1 as novel therapeutics for multiple sclerosisRash, Lachlan, Waqar, Maleeha, Butcher, Neville and Khan, Nemat (2024). Development of venom peptide inhibitors of acid-sensing ion channel 1 as novel therapeutics for multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November-1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Insights into the role of acid sensing ion channels in the pathophysiology of multiple sclerosisWaqar, Maleeha, Khan, Nemat, Butcher, Neville and Rash, Lachlan (2024). Insights into the role of acid sensing ion channels in the pathophysiology of multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November-1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Developing novel acid-sensing ion channel inhibitor as a neuroprotective lead for multiple sclerosisKhan, Nemat, Waqar, Maleeha, Butcher, Neville and Rash, Lachlan (2024). Developing novel acid-sensing ion channel inhibitor as a neuroprotective lead for multiple sclerosis. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. doi: 10.1177/13524585241269220 |
|
2024 Conference Publication Understanding the role of acid sensing ion channels as targets of neuroprotection in the pathophysiology of multiple sclerosisWaqar, Maleeha, Rash, Lachlan, Butcher, Neville and Khan, Nemat (2024). Understanding the role of acid sensing ion channels as targets of neuroprotection in the pathophysiology of multiple sclerosis. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. doi: 10.1177/13524585241269220 |
|
2019 Conference Publication Regulation of MMP9 expression by human arylamine N-acetyltransferase (NAT1) via Hif-1aLi, P., Minchin, R. F. and Butcher, N. (2019). Regulation of MMP9 expression by human arylamine N-acetyltransferase (NAT1) via Hif-1a. ESMO Breast Cancer, Berlin, Germany, 2-4 May 2019 . Amsterdam, Netherlands: Elsevier. |
|
2014 Conference Publication Targeting the Arylamine N-Acetyltransferases in CancerMinchin, Rodney F. and Butcher, Neville J. (2014). Targeting the Arylamine N-Acetyltransferases in Cancer. 10th International Meeting of the International Society for the Study of Xenobiotics (ISSX), Toronto, Canada, 29 September - 03 October 2013. New York, United States: Informa Healthcare. |
|
2008 Conference Publication Current trends in N-acetyltransferase research arising from the 2007 International NAT WorkshopBoukouvala, S., Westwood, I. M., Butcher, N. J. and Fakis, G. U. (2008). Current trends in N-acetyltransferase research arising from the 2007 International NAT Workshop. The United Kingdom: Future Medicine Limited. doi: 10.2217/14622416.9.6.765 |
